In this study, initial in vitro experiments demonstrated that macrophage phenotype affects migration of metastatic breast cancer cells, with anti-inflammatory phenotype (IL-4-stimulated) leading to increased migration compared to pro-inflammatory phenotype (LPS-stimulated). Here, IL4 is linked to breast cancer.